Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites

NCT01013116 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

BIOLOGICAL: modified allergen extract of house dust mites
BIOLOGICAL: placebo

Sponsor

Roxall Medizin